Moderna Shares Slump Amid Concerns About COVID-19 Vaccine Demand
- Investing News
admin
- 0
- 1 minute read
Moderna shares fell to an almost three-year low after the biotech firm reiterated its full-year guidance but warned it couldn’t yet predict COVID-19 vaccine demand.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2007594509-ba97533a0736449eb4661aa3324f7d5b.jpg "Why Should I Pay Myself First?")